Showing results (1-10 of 1,616) with videos related to

Sort By:
Pageof 162
Journal of Crohn'S & Colitis|August 3, 2016
Patient Perspectives on Biosimilars: A Survey by the European Federation of Crohn's and Ulcerative Colitis AssociationsLaurent Peyrin-Biroulet, Sanna Lönnfors, Xavier Roblin, et al.
Inflammatory Bowel Diseases|June 5, 2021
Selective Tyrosine Kinase 2 Inhibition for Treatment of Inflammatory Bowel Disease: New Hope on the RiseSilvio Danese, Laurent Peyrin-Biroulet
Nature Reviews. Gastroenterology & Hepatology|December 25, 2013
IBD in 2013: enriching the therapeutic armamentarium for IBDSilvio Danese, Laurent Peyrin-Biroulet
Journal of Digestive Diseases|September 1, 2017
Adherence to infliximab therapy in inflammatory bowel disease patients in a real-life settingLaura Martelli, Anthony Lopez, Sophie Strobel, et al.
Nature Reviews. Gastroenterology & Hepatology|October 13, 2016
Biosimilars in IBD: from theory to practiceSilvio Danese, Stefanos Bonovas, Laurent Peyrin-Biroulet
Expert Review of Clinical Immunology|February 7, 2017
JAK inhibition in inflammatory bowel diseasePablo Olivera, Silvio Danese, Laurent Peyrin-Biroulet
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 27, 2020
Positioning Therapies in Ulcerative ColitisSilvio Danese, Gionata Fiorino, Laurent Peyrin-Biroulet
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 11, 2020
Systematic Review on Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: It Is Time to Take StockFerdinando D'Amico, Silvio Danese, Laurent Peyrin-Biroulet
Expert Opinion on Biological Therapy|January 18, 2020
Vedolizumab and etrolizumab for ulcerative colitis: twins or simple cousins?Ferdinando D'Amico, Silvio Danese, Laurent Peyrin-Biroulet
Pageof 162